Note: Not all species have been tested for usefulness with this product. Only those species listed have been tested. We cannot make any guarantees about additional reactivities which may or may not occur.
This antibody reacts with the human and mouse proteins. Other species have not been tested.
Applications:
Uses:
NB600-1384 has been shown to work on human malignant brain tumors, breast cancer, leukemia samples, and murine cells. LC3-I is seen at ~18 kDa and LC3-II at ~16 kDa.
Dilutions:
Flow Cytometry 1:200, Immunocytochemistry 1:2000, Immunofluorescence 1:2000, Immunohistochemistry-Frozen 1:2000, Western Blot 1:3000
Aliquot and store at -20 °C or -80 °C. Avoid freeze-thaw cycles.
Buffer:
Tris-glycine (.09M Glycine, .1M Tris), 150mM NaCl
Preservative:
0.05% Sodium Azide
Limitations:
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Products are guaranteed for 6 months from date of receipt, except for peptides and proteins which are guaranteed for 3 months.
Autophagy is a process of intracellular bulk degradation in which cytoplasmic components, including organelles, are sequestered within double-membrane vesicles that deliver the contents to the lysosome/vacuole for degradation. During macroautophagy, the sequestering vesicles, termed autophagosomes, fuse with the lysosome or vacuole resulting in the delivery of an inner vesicle (autophagic body) into the lumen of the degradative compartment. There are 16 proteins participating in the autophagy pathway in humans. The autophagy protein LC3, a mammalian homologue of Atg8, was originally identified as microtubule-associated protein 1 light chain 3. It is a component of both the MAP1A and MAP1B microtubule-binding domains and the heavy-chain independent regulation of LC3 expression may modify MAP1 microtubule-binding activity during development. LC3 is the only known mammalian protein identified that stably
associates with the autophagosome membranes. LC3-I is cytosolic and LC3-II is membrane bound and enriched in the autophagic vacuole fraction. The detection of LC3-I to LC3-II conversion is a useful and sensitive marker for distinguishing autophagy in mammalian cells.
Flow Cytometry: LC3 Antibody [NB600-1384] FACS staining of NTERA-2 cells using NB600-1384 at a 1:200 dilution detected using Dylight-488 conjugated goat anti-rabbit IgG secondary
Immunohistochemistry: LC3B antibody [NB600-1384] - LC3B staining in gliobastoma multiform tissue using NB600-1384.
Immunohistochemistry: LC3B antibody [NB600-1384] - LC3B staining in treated U87-MG cultured & subcutaneous tumors using NB600-1384.
Immunofluorescence: LC3B Antibody [NB600-1384] - Immunofluorescent staining of treated U373-MG cells using NB600-1384. The nuclei were stained with DAPI.
Immunocytochemistry: LC3B antibody [NB600-1384] - Staining of treated U373-MG (human glioblastoma) cells using NB600-1384.
Western Blot: LC3B antibody [NB600-1384] - Detection of LC3B in treated U87-MG (human glioblastoma astrocytoma) lysates using NB600-1384.